Graeme Kaufman

Graeme Kaufman is an accomplished professional with a diverse background in the fields of finance, biopharmaceuticals, and corporate strategy.

He holds an MBA in Capital Markets and a BSc in Chemistry and Biochemistry from the University of Melbourne, showcasing his strong educational foundation.

Throughout his career, Graeme has held various leadership positions in reputable organizations, demonstrating his extensive experience and expertise.

He is currently the Owner of Innovix Pty Ltd, reflecting his entrepreneurial spirit and business acumen.

Graeme's previous roles include Executive Director, Executive Chairman, and Director at IDT Australia Ltd, highlighting his strategic leadership skills.

His past experiences as Chairman at Paradigm Biopharmaceuticals and Bionomics Ltd demonstrate his proficiency in the biopharmaceutical industry.

Having served in leadership roles at Mesoblast, Cellmid Limited, and Bionomics Ltd, Graeme has a strong background in corporate finance and strategic development.

His tenure at reputable organizations like CSL, where he held the positions of General Manager Biosciences, Chief Financial Officer, and Production Director, showcases his depth of experience in the biopharmaceutical sector.

Graeme's career journey includes diverse roles ranging from Chief Investment Officer at Strategic Life Sciences Limited to Various manufacturing roles at CSL, illustrating his versatility and adaptability in different functions within the industry.